Vaccino anti febbre gialla (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vaccino anti febbre gialla" in Italian language version.

refsWebsite

Global rank Italian rank

23nih.gov

4^th place

9^th place

13doi.org

2^nd place

7^th place

7oadoi.org

799^th place

22^nd place

4oxfordjournals.org

1,389^th place

732^nd place

1plos.org

2,112^th place

2,144^th place

1rupress.org

low place

6,584^th place

1who.int

195^th place

342^nd place

1ajtmh.org

low place

1wkhealth.com

low place

7,876^th place

1doai.io

low place

3,405^th place

1salute.gov.it

low place

615^th place

ajtmh.org

Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T, The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review, in The American Journal of Tropical Medicine and Hygiene, vol. 86, n. 2, febbraio 2012, pp. 359–72, DOI:10.4269/ajtmh.2012.11-0525, PMC 3269291, PMID 22302874. URL consultato l'11 dicembre 2014.

doai.io

Barte H, Horvath TH, Rutherford GW, Yellow fever vaccine for patients with HIV infection, in The Cochrane Database of Systematic Reviews, vol. 1, 2014, pp. CD010929, DOI:10.1002/14651858.CD010929.pub2, PMID 24453061. URL consultato il 12 dicembre 2014.

doi.org

dx.doi.org

Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG, Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial, in Plos One, vol. 3, n. 4, 2008, pp. e1993, DOI:10.1371/journal.pone.0001993, PMC 2297511, PMID 18431480. URL consultato l'11 dicembre 2014.
Norrby E, Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine, in The Journal of Experimental Medicine, vol. 204, n. 12, novembre 2007, pp. 2779–84, DOI:10.1084/jem.20072290, PMC 2118520, PMID 18039952. URL consultato l'11 dicembre 2014.
Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T, Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review, in Vaccine, vol. 29, n. 28, giugno 2011, pp. 4544–55, DOI:10.1016/j.vaccine.2011.04.055, PMID 21549787. URL consultato l'11 dicembre 2014.
Bae HG, Domingo C, Tenorio A, de Ory F, Muñoz J, Weber P, Teuwen DE, Niedrig M, Immune response during adverse events after 17D-derived yellow fever vaccination in Europe, in The Journal of Infectious Diseases, vol. 197, n. 11, giugno 2008, pp. 1577–84, DOI:10.1086/587844, PMID 18419548. URL consultato il 12 dicembre 2014.
Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD, Hepatitis and death following vaccination with 17D-204 yellow fever vaccine, in Lancet, vol. 358, n. 9276, luglio 2001, pp. 121–2, DOI:10.1016/S0140-6736(01)05341-7, PMID 11463415. URL consultato il 12 dicembre 2014.
Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, Cetron MS, Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events, in Vaccine, vol. 23, n. 25, maggio 2005, pp. 3256–63, DOI:10.1016/j.vaccine.2005.01.089, PMID 15837230. URL consultato il 12 dicembre 2014.
Rafferty E, Duclos P, Yactayo S, Schuster M, Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review, in Vaccine, vol. 31, n. 49, dicembre 2013, pp. 5798–805, DOI:10.1016/j.vaccine.2013.09.030, PMID 24079979. URL consultato il 12 dicembre 2014.
Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, Adverse event reports following yellow fever vaccination, in Vaccine, vol. 26, n. 48, pp. 6077–82, DOI:10.1016/j.vaccine.2008.09.009, PMID 18809449. URL consultato il 12 dicembre 2014.
Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T, The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review, in The American Journal of Tropical Medicine and Hygiene, vol. 86, n. 2, febbraio 2012, pp. 359–72, DOI:10.4269/ajtmh.2012.11-0525, PMC 3269291, PMID 22302874. URL consultato l'11 dicembre 2014.
Veit O, Niedrig M, Chapuis-Taillard C, Cavassini M, Mossdorf E, Schmid P, Bae HG, Litzba N, Staub T, Hatz C, Furrer H, Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients, in Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 48, n. 5, marzo 2009, pp. 659–66, DOI:10.1086/597006, PMID 19191654. URL consultato il 12 dicembre 2014.
Barte H, Horvath TH, Rutherford GW, Yellow fever vaccine for patients with HIV infection, in The Cochrane Database of Systematic Reviews, vol. 1, 2014, pp. CD010929, DOI:10.1002/14651858.CD010929.pub2, PMID 24453061. URL consultato il 12 dicembre 2014.
Bruyand M, Receveur MC, Pistone T, Verdière CH, Thiebaut R, Malvy D, [Yellow fever vaccination in non-immunocompetent patients], in Médecine Et Maladies Infectieuses, vol. 38, n. 10, ottobre 2008, pp. 524–32, DOI:10.1016/j.medmal.2008.06.031, PMID 18715730. URL consultato l'11 dicembre 2014.
Nascimento Silva JR, Camacho LA, Siqueira MM, Freire Mde S, Castro YP, Maia Mde L, Yamamura AM, Martins RM, Leal Mde L, Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella, in Vaccine, vol. 29, n. 37, agosto 2011, pp. 6327–34, DOI:10.1016/j.vaccine.2011.05.019, PMID 21640779. URL consultato il 12 dicembre 2014.

nih.gov

ncbi.nlm.nih.gov

Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG, Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial, in Plos One, vol. 3, n. 4, 2008, pp. e1993, DOI:10.1371/journal.pone.0001993, PMC 2297511, PMID 18431480. URL consultato l'11 dicembre 2014.
Norrby E, Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine, in The Journal of Experimental Medicine, vol. 204, n. 12, novembre 2007, pp. 2779–84, DOI:10.1084/jem.20072290, PMC 2118520, PMID 18039952. URL consultato l'11 dicembre 2014.
Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T, Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review, in Vaccine, vol. 29, n. 28, giugno 2011, pp. 4544–55, DOI:10.1016/j.vaccine.2011.04.055, PMID 21549787. URL consultato l'11 dicembre 2014.
J. Erin Staples, Joseph A. Bocchini e Lorry Rubin, Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015, in MMWR. Morbidity and mortality weekly report, vol. 64, n. 23, 19 giugno 2015, pp. 647–650. URL consultato il 17 settembre 2017.
Bae HG, Domingo C, Tenorio A, de Ory F, Muñoz J, Weber P, Teuwen DE, Niedrig M, Immune response during adverse events after 17D-derived yellow fever vaccination in Europe, in The Journal of Infectious Diseases, vol. 197, n. 11, giugno 2008, pp. 1577–84, DOI:10.1086/587844, PMID 18419548. URL consultato il 12 dicembre 2014.
Vaccines and vaccination against yellow fever. WHO position paper -- June 2013, in Relevé Épidémiologique Hebdomadaire / Section D'hygiène Du Secrétariat De La Société Des Nations = Weekly Epidemiological Record / Health Section of the Secretariat of the League of Nations, vol. 88, n. 27, luglio 2013, pp. 269–83, PMID 23909008.
Martin M, Tsai TF, Cropp B, Chang GJ, Holmes DA, Tseng J, Shieh W, Zaki SR, Al-Sanouri I, Cutrona AF, Ray G, Weld LH, Cetron MS, Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases, in Lancet, vol. 358, n. 9276, luglio 2001, pp. 98–104, PMID 11463410.
Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD, Hepatitis and death following vaccination with 17D-204 yellow fever vaccine, in Lancet, vol. 358, n. 9276, luglio 2001, pp. 121–2, DOI:10.1016/S0140-6736(01)05341-7, PMID 11463415. URL consultato il 12 dicembre 2014.
Vasconcelos PF, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VL, Monath TP, Rodigues SG, Laval C, Costa ZG, Vilela MF, Santos CL, Papaiordanou PM, Alves VA, Andrade LD, Sato HK, Rosa ES, Froguas GB, Lacava E, Almeida LM, Cruz AC, Rocco IM, Santos RT, Oliva OF, Papaiordanou CM, Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases, in Lancet, vol. 358, n. 9276, luglio 2001, pp. 91–7, PMID 11463409.
Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, Cetron MS, Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events, in Vaccine, vol. 23, n. 25, maggio 2005, pp. 3256–63, DOI:10.1016/j.vaccine.2005.01.089, PMID 15837230. URL consultato il 12 dicembre 2014.
Rafferty E, Duclos P, Yactayo S, Schuster M, Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review, in Vaccine, vol. 31, n. 49, dicembre 2013, pp. 5798–805, DOI:10.1016/j.vaccine.2013.09.030, PMID 24079979. URL consultato il 12 dicembre 2014.
Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, Adverse event reports following yellow fever vaccination, in Vaccine, vol. 26, n. 48, pp. 6077–82, DOI:10.1016/j.vaccine.2008.09.009, PMID 18809449. URL consultato il 12 dicembre 2014.
Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T, The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review, in The American Journal of Tropical Medicine and Hygiene, vol. 86, n. 2, febbraio 2012, pp. 359–72, DOI:10.4269/ajtmh.2012.11-0525, PMC 3269291, PMID 22302874. URL consultato l'11 dicembre 2014.
Veit O, Niedrig M, Chapuis-Taillard C, Cavassini M, Mossdorf E, Schmid P, Bae HG, Litzba N, Staub T, Hatz C, Furrer H, Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients, in Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 48, n. 5, marzo 2009, pp. 659–66, DOI:10.1086/597006, PMID 19191654. URL consultato il 12 dicembre 2014.
Sibailly TS, Wiktor SZ, Tsai TF, Cropp BC, Ekpini ER, Adjorlolo-Johnson G, Gnaore E, DeCock KM, Greenberg AE, Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1 ^{[collegamento interrotto]}, in The Pediatric Infectious Disease Journal, vol. 16, n. 12, dicembre 1997, pp. 1177–9, PMID 9427466. URL consultato il 12 dicembre 2014.
Barte H, Horvath TH, Rutherford GW, Yellow fever vaccine for patients with HIV infection, in The Cochrane Database of Systematic Reviews, vol. 1, 2014, pp. CD010929, DOI:10.1002/14651858.CD010929.pub2, PMID 24453061. URL consultato il 12 dicembre 2014.
Bruyand M, Receveur MC, Pistone T, Verdière CH, Thiebaut R, Malvy D, [Yellow fever vaccination in non-immunocompetent patients], in Médecine Et Maladies Infectieuses, vol. 38, n. 10, ottobre 2008, pp. 524–32, DOI:10.1016/j.medmal.2008.06.031, PMID 18715730. URL consultato l'11 dicembre 2014.
Nasidi A, Monath TP, Vandenberg J, Tomori O, Calisher CH, Hurtgen X, Munube GR, Sorungbe AO, Okafor GC, Wali S, Yellow fever vaccination and pregnancy: a four-year prospective study, in Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, n. 3, 1993, pp. 337–9, PMID 8236412.
Tsai TF, Paul R, Lynberg MC, Letson GW, Congenital yellow fever virus infection after immunization in pregnancy, in The Journal of Infectious Diseases, vol. 168, n. 6, dicembre 1993, pp. 1520–3, PMID 8245539. URL consultato l'11 dicembre 2014.
Cetron MS, Marfin AA, Julian KG, Gubler DJ, Sharp DJ, Barwick RS, Weld LH, Chen R, Clover RD, Deseda-Tous J, Marchessault V, Offit PA, Monath TP, Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002, in MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports / Centers for Disease Control, vol. 51, RR-17, novembre 2002, pp. 1–11; quiz CE1–4, PMID 12437192.
Nascimento Silva JR, Camacho LA, Siqueira MM, Freire Mde S, Castro YP, Maia Mde L, Yamamura AM, Martins RM, Leal Mde L, Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella, in Vaccine, vol. 29, n. 37, agosto 2011, pp. 6327–34, DOI:10.1016/j.vaccine.2011.05.019, PMID 21640779. URL consultato il 12 dicembre 2014.
Gateff C, Dodin A, Wiart J, [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)], in Annales De Microbiologie, vol. 126, n. 2, 1975, pp. 231–46, PMID 1098542.
Kollaritsch H, Que JU, Kunz C, Wiedermann G, Herzog C, Cryz SJ, Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine, in The Journal of Infectious Diseases, vol. 175, n. 4, aprile 1997, pp. 871–5, PMID 9086143. URL consultato il 12 dicembre 2014.

oadoi.org

Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T, Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review, in Vaccine, vol. 29, n. 28, giugno 2011, pp. 4544–55, DOI:10.1016/j.vaccine.2011.04.055, PMID 21549787. URL consultato l'11 dicembre 2014.
Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD, Hepatitis and death following vaccination with 17D-204 yellow fever vaccine, in Lancet, vol. 358, n. 9276, luglio 2001, pp. 121–2, DOI:10.1016/S0140-6736(01)05341-7, PMID 11463415. URL consultato il 12 dicembre 2014.
Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, Cetron MS, Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events, in Vaccine, vol. 23, n. 25, maggio 2005, pp. 3256–63, DOI:10.1016/j.vaccine.2005.01.089, PMID 15837230. URL consultato il 12 dicembre 2014.
Rafferty E, Duclos P, Yactayo S, Schuster M, Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review, in Vaccine, vol. 31, n. 49, dicembre 2013, pp. 5798–805, DOI:10.1016/j.vaccine.2013.09.030, PMID 24079979. URL consultato il 12 dicembre 2014.
Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, Adverse event reports following yellow fever vaccination, in Vaccine, vol. 26, n. 48, pp. 6077–82, DOI:10.1016/j.vaccine.2008.09.009, PMID 18809449. URL consultato il 12 dicembre 2014.
Bruyand M, Receveur MC, Pistone T, Verdière CH, Thiebaut R, Malvy D, [Yellow fever vaccination in non-immunocompetent patients], in Médecine Et Maladies Infectieuses, vol. 38, n. 10, ottobre 2008, pp. 524–32, DOI:10.1016/j.medmal.2008.06.031, PMID 18715730. URL consultato l'11 dicembre 2014.
Nascimento Silva JR, Camacho LA, Siqueira MM, Freire Mde S, Castro YP, Maia Mde L, Yamamura AM, Martins RM, Leal Mde L, Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella, in Vaccine, vol. 29, n. 37, agosto 2011, pp. 6327–34, DOI:10.1016/j.vaccine.2011.05.019, PMID 21640779. URL consultato il 12 dicembre 2014.

oxfordjournals.org

jid.oxfordjournals.org

Bae HG, Domingo C, Tenorio A, de Ory F, Muñoz J, Weber P, Teuwen DE, Niedrig M, Immune response during adverse events after 17D-derived yellow fever vaccination in Europe, in The Journal of Infectious Diseases, vol. 197, n. 11, giugno 2008, pp. 1577–84, DOI:10.1086/587844, PMID 18419548. URL consultato il 12 dicembre 2014.
Tsai TF, Paul R, Lynberg MC, Letson GW, Congenital yellow fever virus infection after immunization in pregnancy, in The Journal of Infectious Diseases, vol. 168, n. 6, dicembre 1993, pp. 1520–3, PMID 8245539. URL consultato l'11 dicembre 2014.
Kollaritsch H, Que JU, Kunz C, Wiedermann G, Herzog C, Cryz SJ, Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine, in The Journal of Infectious Diseases, vol. 175, n. 4, aprile 1997, pp. 871–5, PMID 9086143. URL consultato il 12 dicembre 2014.

cid.oxfordjournals.org

Veit O, Niedrig M, Chapuis-Taillard C, Cavassini M, Mossdorf E, Schmid P, Bae HG, Litzba N, Staub T, Hatz C, Furrer H, Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients, in Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 48, n. 5, marzo 2009, pp. 659–66, DOI:10.1086/597006, PMID 19191654. URL consultato il 12 dicembre 2014.

plos.org

dx.plos.org

Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG, Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial, in Plos One, vol. 3, n. 4, 2008, pp. e1993, DOI:10.1371/journal.pone.0001993, PMC 2297511, PMID 18431480. URL consultato l'11 dicembre 2014.

rupress.org

jem.rupress.org

Norrby E, Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine, in The Journal of Experimental Medicine, vol. 204, n. 12, novembre 2007, pp. 2779–84, DOI:10.1084/jem.20072290, PMC 2118520, PMID 18039952. URL consultato l'11 dicembre 2014.

salute.gov.it

http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=2602

who.int

(EN) Yellow fever, su World Health Organization. URL consultato il 17 settembre 2017.

wkhealth.com

meta.wkhealth.com

Sibailly TS, Wiktor SZ, Tsai TF, Cropp BC, Ekpini ER, Adjorlolo-Johnson G, Gnaore E, DeCock KM, Greenberg AE, Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1 ^{[collegamento interrotto]}, in The Pediatric Infectious Disease Journal, vol. 16, n. 12, dicembre 1997, pp. 1177–9, PMID 9427466. URL consultato il 12 dicembre 2014.